Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/26 16:24 | 4/1/26 | TECX | Health | BioPrd | Biological Products, (No Diag | Ruddy Marcella K. | MA | O | Chief Me | S | -31 | 31.05 | 0 | -1 | -1 | 69 | D | ||||||||||||||
3/9/26 18:15 | 3/6/26 | TECX | Health | BioPrd | Biological Products, (No Diag | Ruddy Marcella K. | MA | O | Chief Me | S | -300 | 30.00 | 0 | -10 | -13 | 70 | D | ||||||||||||||
3/9/26 18:12 | 3/6/26 | TECX | Health | BioPrd | Biological Products, (No Diag | McNamara Peter | MA | O | Chief Sc | S.d | -189 | 30.17 | 0 | -6 | -10 | 55 | D | ||||||||||||||
3/5/26 17:45 | 3/3/26 | TECX | Health | BioPrd | Biological Products, (No Diag | McNamara Peter | MA | O | Chief Sc | S.dm | -78 | 23.53 | 0 | -3 | -5 | 59 | D | ||||||||||||||
4/7/25 17:02 | 4/7/25 | TECX | Health | BioPrd | Biological Products, (No Diag | McGuire Terrance | MA | D | S | -8,550 | 17.10 | 0 | -500 | -43 | 658 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |